Skip to main content
SpringerLink
Log in

Possible link between fingolimod use and T wave inversion?

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Uppsala Monitoring Centre. Fingolimod and T wave inversion. WHO Pharmaceuticals Newsletter : 21-23, No. 5, Oct 2014. Available from: URL: http://www.who.int/medicines/publications/PharmNewsletter5_14..pdf?ua=1

  2. Novartis. Response from Novartis (re: Fingolimod and T wave inversion). WHO Pharmaceuticals Newsletter : 23-25, No. 5, Oct 2014. Available from: URL: http://www.who.int/medicines/publications/PharmNewsletter5_14..pdf?ua=1

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Possible link between fingolimod use and T wave inversion?. Reactions Weekly 1527, 5 (2014). https://doi.org/10.1007/s40278-014-4799-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-014-4799-1

Search

Navigation